Share Price and Basic Stock Data
Last Updated: October 26, 2025, 8:17 am
| PEG Ratio | -2.81 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Deccan Cements Ltd operates in the cement industry, with a current market capitalization of ₹1,465 Cr. The company recorded a share price of ₹1,046, reflecting a price-to-earnings ratio (P/E) of 73.0. Over the past few quarters, the company has experienced fluctuations in sales, with the most recent quarterly sales reported at ₹167 Cr in September 2023, down from ₹192 Cr in June 2023. However, the company demonstrated resilience with a recovery in December 2023, reporting sales of ₹217 Cr. The annual sales figures have also shown variability, with ₹782 Cr reported for FY 2023, slightly increasing to ₹799 Cr for FY 2024. The trailing twelve months (TTM) sales stood at ₹505 Cr, indicating a downward trend from the previous fiscal year. This volatility in revenue underscores the challenges faced by the cement sector, which is often influenced by economic cycles, construction activity, and infrastructure projects across India.
Profitability and Efficiency Metrics
Deccan Cements’ profitability metrics reveal a mixed performance amid rising costs. The operating profit margin (OPM) for the latest quarter was 8%, down from 13% in June 2023, indicating a decline in operational efficiency. The net profit for the same quarter was ₹5 Cr, significantly lower than the ₹14 Cr recorded in June 2023. Over the fiscal years, net profit has seen a downward trend, declining to ₹49 Cr in FY 2023 from ₹88 Cr in FY 2022, with projections for FY 2025 showing a further drop to ₹8 Cr. The return on equity (ROE) currently stands at 0.75%, while the return on capital employed (ROCE) is at 1.53%, both of which are substantially lower than typical sector averages, indicating potential operational inefficiencies. Additionally, the interest coverage ratio (ICR) is reported at 4.04x, suggesting that while the company can cover its interest obligations, the declining profit margins raise concerns about future profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Deccan Cements reflects a cautious financial position, with total borrowings reported at ₹714 Cr against reserves of ₹715 Cr. This indicates a leveraged position, with a debt-to-equity ratio of 0.98, which is relatively high compared to industry norms. The current ratio of 1.17 and quick ratio of 0.82 suggest that while the company can meet its short-term liabilities, there is limited liquidity for immediate operational needs. The book value per share is ₹515.74, and the price-to-book value (P/BV) ratio stands at 1.52x, indicating that the market values the company slightly above its book value. The cash conversion cycle (CCC) reported at 386 days reflects inefficiencies in managing working capital, particularly with inventory days at 541 and debtor days at 40, suggesting that the company may face challenges in converting its sales into cash flow.
Shareholding Pattern and Investor Confidence
Deccan Cements’ shareholding pattern indicates a stable ownership structure, with promoters holding 56.24% of the company. Foreign institutional investors (FIIs) have increased their stake to 9.93%, while domestic institutional investors (DIIs) hold a marginal 0.90%. The public shareholding accounts for 32.92%, which reflects a healthy distribution of shares among retail investors. Over recent quarters, the number of shareholders has declined from 17,605 in December 2022 to 11,952 by March 2025, indicating potential attrition of retail interest or consolidation by larger investors. This decline may raise concerns about investor confidence, particularly given the company’s recent profitability challenges. However, the consistent promoter holding suggests a long-term commitment to the company’s growth, which can provide reassurance to investors amidst fluctuating market conditions.
Outlook, Risks, and Final Insight
Looking ahead, Deccan Cements faces a challenging landscape, with risks stemming from declining profitability and high leverage. The volatility in sales and profit margins raises concerns about the company’s ability to sustain operations effectively, particularly in a competitive cement market. However, the stable promoter holding and potential recovery in construction demand may provide a buffer against these risks. Should the company successfully manage its operating costs and improve efficiency, there is potential for recovery in profitability. Conversely, continued operational inefficiencies and rising input costs could further strain margins. Investors should remain vigilant regarding the company’s ability to navigate these challenges, as its financial health will be crucial in determining future performance and shareholder returns.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Deccan Cements Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 24.0/16.2 | 3.95 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,51,199 Cr. | 11,918 | 13,102/10,048 | 47.9 | 2,444 | 0.65 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 24,735 Cr. | 1,047 | 1,209/788 | 172 | 317 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 12,095 Cr. | 390 | 413/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 10,145 Cr. | 251 | 309/172 | 42.9 | 71.2 | 0.40 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 35,936.96 Cr | 2,031.22 | 44.05 | 559.44 | 0.50% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 180 | 211 | 196 | 192 | 167 | 217 | 223 | 172 | 120 | 115 | 119 | 151 |
| Expenses | 159 | 164 | 186 | 175 | 167 | 154 | 188 | 197 | 161 | 118 | 107 | 106 | 123 |
| Operating Profit | 35 | 17 | 25 | 21 | 25 | 14 | 29 | 26 | 11 | 2 | 9 | 13 | 28 |
| OPM % | 18% | 9% | 12% | 10% | 13% | 8% | 13% | 12% | 7% | 2% | 8% | 11% | 19% |
| Other Income | 3 | 2 | 2 | 3 | 3 | 4 | 4 | -11 | 3 | 3 | 3 | 7 | 3 |
| Interest | 3 | 3 | 3 | 4 | 2 | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 3 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | 28 | 9 | 17 | 13 | 19 | 8 | 22 | 5 | 4 | -5 | 1 | 10 | 20 |
| Tax % | 25% | 27% | 26% | 26% | 26% | 38% | 30% | 36% | 35% | -26% | 45% | 24% | 25% |
| Net Profit | 21 | 7 | 12 | 10 | 14 | 5 | 15 | 3 | 3 | -4 | 1 | 8 | 15 |
| EPS in Rs | 14.76 | 4.69 | 8.68 | 7.07 | 10.09 | 3.38 | 10.99 | 2.15 | 2.01 | -2.88 | 0.58 | 5.68 | 10.96 |
Last Updated: August 20, 2025, 11:45 am
Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 151.00 Cr., marking an increase of 32.00 Cr..
- For Expenses, as of Jun 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 106.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 15.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Mar 2025) to 19.00%, marking an increase of 8.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 10.96. The value appears strong and on an upward trend. It has increased from 5.68 (Mar 2025) to 10.96, marking an increase of 5.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 407 | 625 | 496 | 570 | 651 | 555 | 758 | 792 | 782 | 799 | 527 | 505 |
| Expenses | 383 | 343 | 511 | 396 | 484 | 556 | 477 | 582 | 630 | 684 | 704 | 492 | 453 |
| Operating Profit | 57 | 64 | 115 | 100 | 86 | 95 | 79 | 176 | 162 | 97 | 96 | 35 | 52 |
| OPM % | 13% | 16% | 18% | 20% | 15% | 15% | 14% | 23% | 20% | 12% | 12% | 7% | 10% |
| Other Income | 2 | 3 | 1 | 2 | 3 | 10 | -0 | 10 | -8 | 9 | -2 | 16 | 16 |
| Interest | 27 | 27 | 15 | 7 | 6 | 8 | 7 | 8 | 10 | 13 | 13 | 13 | 13 |
| Depreciation | 24 | 19 | 20 | 22 | 23 | 22 | 21 | 23 | 26 | 27 | 28 | 28 | 28 |
| Profit before tax | 7 | 21 | 81 | 74 | 61 | 75 | 51 | 155 | 117 | 67 | 53 | 11 | 27 |
| Tax % | 33% | 6% | 43% | 36% | 37% | 39% | -12% | 26% | 25% | 26% | 30% | 30% | |
| Net Profit | 5 | 20 | 46 | 47 | 39 | 46 | 57 | 115 | 88 | 49 | 37 | 8 | 20 |
| EPS in Rs | 3.59 | 14.20 | 32.54 | 33.48 | 27.52 | 32.88 | 40.44 | 82.19 | 62.52 | 35.20 | 26.60 | 5.38 | 14.34 |
| Dividend Payout % | 17% | 9% | 8% | 9% | 11% | 11% | 10% | 6% | 8% | 11% | 11% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 300.00% | 130.00% | 2.17% | -17.02% | 17.95% | 23.91% | 101.75% | -23.48% | -44.32% | -24.49% | -78.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -170.00% | -127.83% | -19.20% | 34.97% | 5.96% | 77.84% | -125.23% | -20.84% | 19.83% | -53.89% |
Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -35% |
| 3 Years: | -58% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 28% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: June 16, 2025, 12:14 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 223 | 238 | 279 | 325 | 358 | 399 | 443 | 558 | 639 | 680 | 712 | 715 |
| Borrowings | 239 | 191 | 79 | 70 | 33 | 54 | 106 | 104 | 166 | 265 | 520 | 714 |
| Other Liabilities | 119 | 114 | 127 | 132 | 161 | 161 | 155 | 193 | 173 | 202 | 207 | 189 |
| Total Liabilities | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 |
| Fixed Assets | 373 | 356 | 342 | 377 | 363 | 354 | 378 | 446 | 453 | 440 | 423 | 402 |
| CWIP | 35 | 33 | 34 | 0 | 4 | 9 | 62 | 12 | 21 | 241 | 514 | 805 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 180 | 161 | 116 | 157 | 192 | 258 | 271 | 404 | 511 | 474 | 509 | 417 |
| Total Assets | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 |
Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
- For Reserves, as of Mar 2025, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 712.00 Cr. (Mar 2024) to 715.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Mar 2025, the value is 714.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 520.00 Cr. (Mar 2024) to 714.00 Cr., marking an increase of 194.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 189.00 Cr.. The value appears to be improving (decreasing). It has decreased from 207.00 Cr. (Mar 2024) to 189.00 Cr., marking a decrease of 18.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,625.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,446.00 Cr. (Mar 2024) to 1,625.00 Cr., marking an increase of 179.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 402.00 Cr.. The value appears to be declining and may need further review. It has decreased from 423.00 Cr. (Mar 2024) to 402.00 Cr., marking a decrease of 21.00 Cr..
- For CWIP, as of Mar 2025, the value is 805.00 Cr.. The value appears strong and on an upward trend. It has increased from 514.00 Cr. (Mar 2024) to 805.00 Cr., marking an increase of 291.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 509.00 Cr. (Mar 2024) to 417.00 Cr., marking a decrease of 92.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,625.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,446.00 Cr. (Mar 2024) to 1,625.00 Cr., marking an increase of 179.00 Cr..
Notably, the Reserves (715.00 Cr.) exceed the Borrowings (714.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -182.00 | -127.00 | 36.00 | 30.00 | 53.00 | 41.00 | -27.00 | 72.00 | -4.00 | -168.00 | -424.00 | -679.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 5 | 8 | 9 | 9 | 31 | 12 | 11 | 13 | 25 | 40 |
| Inventory Days | 935 | 712 | 397 | 464 | 364 | 374 | 493 | 341 | 349 | 601 | 408 | 541 |
| Days Payable | 164 | 152 | 150 | 25 | 16 | 27 | 169 | 218 | 132 | 291 | 164 | 194 |
| Cash Conversion Cycle | 793 | 587 | 251 | 446 | 357 | 356 | 355 | 135 | 227 | 323 | 268 | 386 |
| Working Capital Days | 27 | 15 | -2 | 3 | 22 | 10 | 1 | -34 | -51 | -32 | -45 | -65 |
| ROCE % | 7% | 11% | 24% | 21% | 17% | 19% | 13% | 27% | 20% | 9% | 8% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 5.00 |
| Basic EPS (Rs.) | 5.37 |
| Diluted EPS (Rs.) | 5.37 |
| Cash EPS (Rs.) | 25.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 515.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 515.74 |
| Revenue From Operations / Share (Rs.) | 376.21 |
| PBDIT / Share (Rs.) | 36.81 |
| PBIT / Share (Rs.) | 16.77 |
| PBT / Share (Rs.) | 7.67 |
| Net Profit / Share (Rs.) | 5.37 |
| NP After MI And SOA / Share (Rs.) | 5.37 |
| PBDIT Margin (%) | 9.78 |
| PBIT Margin (%) | 4.45 |
| PBT Margin (%) | 2.03 |
| Net Profit Margin (%) | 1.42 |
| NP After MI And SOA Margin (%) | 1.42 |
| Return on Networth / Equity (%) | 1.04 |
| Return on Capital Employeed (%) | 1.76 |
| Return On Assets (%) | 0.46 |
| Long Term Debt / Equity (X) | 0.75 |
| Total Debt / Equity (X) | 0.98 |
| Current Ratio (X) | 1.17 |
| Quick Ratio (X) | 0.82 |
| Dividend Payout Ratio (NP) (%) | 55.89 |
| Dividend Payout Ratio (CP) (%) | 11.80 |
| Earning Retention Ratio (%) | 44.11 |
| Cash Earning Retention Ratio (%) | 88.20 |
| Interest Coverage Ratio (X) | 4.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 |
| Enterprise Value (Cr.) | 1670.92 |
| EV / Net Operating Revenue (X) | 3.17 |
| EV / EBITDA (X) | 32.40 |
| MarketCap / Net Operating Revenue (X) | 2.09 |
| Retention Ratios (%) | 44.10 |
| Price / BV (X) | 1.52 |
| Price / Net Operating Revenue (X) | 2.09 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
- Net Profit Margin: 1.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.76% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.04% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.82
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 71.8 (Industry average Stock P/E: 44.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Deccan Chambers, Hyderabad Telangana 500082 | secretarial@deccancements.com http://www.deccancements.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. P Parvathi | Chairperson & Managing Director |
| Mr. S Venkateswarlu | Whole Time Director |
| Mrs. Mahpara Ali | Director |
| Mr. Paturi Srinivasa Rao | Director |
| Mr. Srivari Chandrasekhar | Director |
| Mr. Rabindra Srikantan | Director |
FAQ
What is the intrinsic value of Deccan Cements Ltd?
Deccan Cements Ltd's intrinsic value (as of 26 October 2025) is 222.43 which is 78.40% lower the current market price of 1,030.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,442 Cr. market cap, FY2025-2026 high/low of 1,184/550, reserves of ₹715 Cr, and liabilities of 1,625 Cr.
What is the Market Cap of Deccan Cements Ltd?
The Market Cap of Deccan Cements Ltd is 1,442 Cr..
What is the current Stock Price of Deccan Cements Ltd as on 26 October 2025?
The current stock price of Deccan Cements Ltd as on 26 October 2025 is 1,030.
What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is 1,184/550.
What is the Stock P/E of Deccan Cements Ltd?
The Stock P/E of Deccan Cements Ltd is 71.8.
What is the Book Value of Deccan Cements Ltd?
The Book Value of Deccan Cements Ltd is 516.
What is the Dividend Yield of Deccan Cements Ltd?
The Dividend Yield of Deccan Cements Ltd is 0.06 %.
What is the ROCE of Deccan Cements Ltd?
The ROCE of Deccan Cements Ltd is 1.53 %.
What is the ROE of Deccan Cements Ltd?
The ROE of Deccan Cements Ltd is 0.75 %.
What is the Face Value of Deccan Cements Ltd?
The Face Value of Deccan Cements Ltd is 5.00.